UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000058436
Receipt number R000066770
Scientific Title Study to confirm absorption of carotenoids in trial foods
Date of disclosure of the study information 2025/07/11
Last modified on 2025/07/11 11:28:39

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Study to confirm absorption of carotenoids in trial foods

Acronym

Study to confirm absorption of carotenoids in trial foods

Scientific Title

Study to confirm absorption of carotenoids in trial foods

Scientific Title:Acronym

Study to confirm absorption of carotenoids in trial foods

Region

Japan


Condition

Condition

Healthy volunteers

Classification by specialty

Not applicable Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To compare the absorption effectiveness of existing and new formulations in humans.

Basic objectives2

Pharmacokinetics

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

AUC of carotenoid (lutein/zeaxanthin/astaxanthin) concentration in blood

Key secondary outcomes

Blood carotenoid concentrations (lutein/ zeaxanthin/ astaxanthin) at each time point and Cmax


Base

Study type

Interventional


Study design

Basic design

Cross-over

Randomization

Randomized

Randomization unit

Individual

Blinding

Double blind -all involved are blinded

Control

Active

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Prevention

Type of intervention

Food

Interventions/Control_1

The trial food will be consumed once, followed by a washout period, then the control food will be consumed once.

Interventions/Control_2

After consuming the control food once, a washout period will follow, and the test food will be consumed once.

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

60 years-old >

Gender

Male and Female

Key inclusion criteria

1) Japanese males and females aged 20 to under 60 at the time of informed consent.
2) Participants who with a BMI >=18.5 kg/m2 and <25kg/m2.
3) Participants who received a full explanation of the study and signed the informed consent form before study initiation.

Key exclusion criteria

1) Participants with a history of serious illness or gastrointestinal surgery.
2) Participants with diseases affecting gastric emptying or digestion/absorption, or who regularly experience symptoms such as indigestion, constipation, or diarrhea.
3) Participants with abnormal kidney or liver function, blood pressure, or glucose/lipid metabolism.
4) Participants who regularly use medications (including Kampo), or quasi-drugs or supplements.
5) Participants who regularly consume health foods (e.g., FOSHU, foods with functional claims) that may affect the study and cannot discontinue them during the study period.
6) Participants who consume excessive amounts of alcohol.
7) Participants who Currently smoke or have smoked within the past year.
8) Participants planning to travel abroad during the study period.
9) Participant with irregular work hours or engaged in shift work.
10) Participants who may be unable to maintain their lifestyle due to dietary restrictions.
11) Participants with food allergies or those who may react to the trial or provided food.
12) Participants who are pregnant, breastfeeding, or planning to become pregnant during the study period.
13) Participants who joined another clinical trial within one month before consent or plan to join one during the study.
14) Participants deemed ineligible by the principal investigator.

Target sample size

20


Research contact person

Name of lead principal investigator

1st name Erika
Middle name
Last name Ono

Organization

FANCL CORPORATION

Division name

Clinical Research Center ,Functional Food Research Institute

Zip code

244-0806

Address

12-13, Kamishinano, Totsuka-ku, Yokohama-shi, Kanagawa, 244-0806, Japan

TEL

045-820-3659

Email

tsubokawa_masaya@fancl.co.jp


Public contact

Name of contact person

1st name Shuka
Middle name
Last name Futagami

Organization

APO PLUS STATION CO., LTD.

Division name

Clinical Operations Dept., CRO Business div.

Zip code

103-0027

Address

2-14-1, Nihonbashi, Chuo-ku, Tokyo, 103-0027, Japan

TEL

03-6777-7789

Homepage URL


Email

food-contact@apoplus.co.jp


Sponsor or person

Institute

APO PLUS STATION CO., LTD.

Institute

Department

Personal name



Funding Source

Organization

FANCL CORPORATION

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Ethics Review Committee of Watanabe Hospital

Address

1-5-16, Haneda, Otaku, Tokyo, 144-0043, Japan

Tel

03-3741-0223

Email

food-contact@apoplus.co.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

医療法人社団 渡辺病院(東京都)


Other administrative information

Date of disclosure of the study information

2025 Year 07 Month 11 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2025 Year 07 Month 11 Day

Date of IRB

2025 Year 07 Month 11 Day

Anticipated trial start date

2025 Year 07 Month 12 Day

Last follow-up date

2025 Year 12 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2025 Year 07 Month 11 Day

Last modified on

2025 Year 07 Month 11 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000066770